- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 390.48M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 127.86M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $337.88M |
| Capex | Q1 2026 · Mar 31, 2025 | $91.64M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$83.35M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $159.41M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $623.59M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $709.07M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $910.69M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.25B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.81B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.96B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.08B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $5.31B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $7.21B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.31B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.94B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.52B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.99B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.35B |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $20.42M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $86.58M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$216.31M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$295.43M |
| Revenue | Q1 2026 · Mar 31, 2026 | $10.01B |
| Revenue | Q1 2026 · Mar 31, 2025 | $12.94B |